Abstract
The University of California, Berkeley, will soon get its long-sought CRISPR gene-editing patent. Berkeley’s patent application was tied up in court for years while the university argued that approved CRISPR patents held by Broad Institute of MIT and Harvard interfered with its patent application, which was submitted first. In September 2018, a US federal court declared that the two parties’ patents didn’t interfere. Now, documents from the US Patent and Trademark Office indicate Berkeley’s pending patent will be issued soon. It’s unclear what will happen next, but companies wishing to use CRISPR will likely need licenses from both parties.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
